Latest News about COVID/19 Vaccine
Recent news which mentions COVID/19 Vaccine
Novavax Scores Another Nod For Its COVID-19 Shot In Adolescents
August 26, 2022
Tickers
NVAX
From Benzinga
From Benzinga
Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know
August 26, 2022
From Benzinga
Dynavax's Adjuvant Based COVID-19 Shot Shows Robust Immune Response, Safety In Younger Populations
August 25, 2022
Tickers
DVAX
From Benzinga
From Benzinga
Moderna Plans US Application Submission For COVID-19 Omicron Adapted Booster 'Very Soon'
August 23, 2022
Tickers
MRNA
From Benzinga
Pfizer/BioNTech's COVID-19 Vaccine Updated Data Shows Around 76% Efficacy In Toddlers
August 23, 2022
From Benzinga
This COVID-19 Shot Stock Could Have Eye Disease Gene Therapy As Significant Driver, Mizuho Analyst Says
August 23, 2022
Tickers
OCGN
From Benzinga
Boosters Are Coming For Dangerous Omicron COVID-19 Variant. Here's Who May Be Rolling Them Out
August 22, 2022
From Benzinga
From Benzinga
FDA Approves Novavax's COVID-19 Vaccine For Use In Adolescents
August 22, 2022
Tickers
NVAX
From Benzinga
FDA Says Study Needed To Assess Another Round Of Pfizer's COVID-19 Pill As Infection Rebounds
August 22, 2022
From Benzinga
Canada OKs Pfizer COVID-19 Booster For Kids Aged 5-11 Years
August 22, 2022
From Benzinga
Fighting Omicron: This Covid Vaccine Candidate Is Going After The Dangerous Mutation
August 18, 2022
From Benzinga
From Benzinga
Valneva Cuts FY22 COVID-19 Vaccine Sales Outlook, Needs Funding To Invest In Next-Gen COVID-19 Shot
August 11, 2022
Tickers
VALN
From Benzinga
Lyme Disease And Climate Change Reinvigorates Valneva's Vaccine Efforts After COVID Shot Disappointment
August 08, 2022
From Benzinga
Icosavax Shifts Focus On Bivalent Strategy For COVID-19 Vaccine Candidate After Antigen Instability Issues
July 29, 2022
Tickers
ICVX
From Benzinga
From Benzinga
InflaRx Shares Are Flying Higher After Emergency Use Nod Plans For Its COVID-19 Treatment
July 26, 2022
Tickers
IFRX
From Benzinga
From Benzinga
Novavax's COVID-19 Vaccine Gets Back To Back Approval In Japan, Australia For Adolescents
July 26, 2022
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|